How should a supplement brand market the results of a clinical study?
A supplement brand should market a clinical study by claiming only what the study measured, in the population and at the dose it tested, framed as a structure/function benefit rather than a disease effect. Check the study against the FTC's quality questions, disclose who funded it, present the data in context, and build every ad, listing and creator brief from one approved claim.
- Claim what was measured: same dose, form, population and outcome, and nothing broader.
- Test the study against FTC questions on controls, blinding, significance, clinical meaning and the totality of evidence.
- Disclose brand funding when you present results as independent findings, as the Endorsement Guides require.
- No disease claims, even if the trial measured symptoms of a condition.
- Every practice welcome — retainers from $499/mo, Goals-Driven engagements, Performance-Linked Payout Models available.
- Dallas, Texas LLC
- US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
What can a clinical study actually let a supplement brand claim?
A study lets you claim what it measured, in the people it studied, at the dose and form it tested, and nothing broader. It can support a structure/function claim for a dietary supplement. It cannot turn a supplement into a product that treats disease, because disease claims are off limits for supplements whatever the evidence says.
Brands often fund a trial and then write the headline they wanted before the data came in. The safer order is the reverse. Read the primary endpoint, the population and the effect, then draft the narrowest honest sentence the results support. Widen it only if other good evidence backs the wider version.
| What the study found | Claim it may support | Claim it does not support |
|---|---|---|
| Improvement on a sleep-quality questionnaire in healthy adults with occasional sleeplessness | "Supports sleep quality" (structure/function, with disclaimer) | "Treats insomnia" or "clinically proven to cure sleep problems" |
| A change in a blood marker, with no change in how participants felt | A careful statement about that marker in healthy people, if counsel agrees it is not a disease claim | A claim that users will feel or perform better |
| Effect seen at a higher dose than your product contains | Nothing for your product, as formulated | Any efficacy claim for your lower dose |
| Effect in older adults only | A claim framed for that group | A claim for all adults |
| Positive result for one ingredient in your blend | A statement about that ingredient, clearly separated from the product's own proof | "Clinically proven formula" |
| Effect on a secondary outcome only | Usually nothing headline-worthy | A headline claim based on that outcome |
Remember the disease line from 21 CFR 101.93(g). A claim about the signs or symptoms of a disease is a disease claim, even if a trial measured those symptoms. Our explainer on FTC and FDA supplement advertising rules covers the line in full.
How do you judge whether a study is strong enough to advertise?
Use the FTC's own questions. Was it a randomized, controlled human trial with blinding? Were results statistically significant and clinically meaningful? Do the dose, formulation, population and duration match your product and claim? And does the full body of research agree, rather than one study standing alone against others?
The FTC's Health Products Compliance Guidance, issued in December 2022, says health benefit claims generally need randomized, controlled human clinical trials. It lists the features regulators look for. Treat the list below as the questions your counsel and your scientific adviser should answer in writing before any campaign brief is written.
The FTC's quality questions
- Control and randomization: a treatment group and a control group, assigned at random.
- Blinding: participants and researchers should not know who got what.
- Significance: results must be statistically significant and translate to a benefit that is clinically meaningful for consumers.
- Fit: the dose and formulation tested should match the product sold, and the study population should match the people the ad targets.
- Duration: long enough to support any claim that the effect lasts.
- Outcomes: all measured outcomes reported, with adjustment for multiple comparisons. Post hoc subgroup findings do not generally substantiate a claim.
- Totality: studies cannot be read in isolation. Do not rely only on supportive research while discounting research that is not.
FDA's nonbinding 2009 guidance on substantiating structure/function claims asks similar questions about study design and the totality of evidence. If both agencies' questions point the same way, you are on firmer ground.
If the study has not started yet
Marketing should have a seat at the design table, because the claim you want shapes the study you need. Agree the exact claim first, then make sure the trial can answer it:
- Test the finished product at the labeled dose, not a lab version of one ingredient.
- Recruit people who look like your buyers, and keep them healthy if you want a structure/function claim.
- Make the primary outcome the benefit you plan to advertise, measured with an accepted tool.
- Run it long enough to match how buyers will use the product.
- Agree in writing that results will be published whatever they show, so you are never accused of hiding a null result.
What do “clinically proven,” “clinically studied” and “clinically tested ingredient” each imply?
"Clinically proven" is an establishment claim: it says the proof exists, so you need the level of evidence that phrase implies. "Clinically studied" implies a study found a benefit, not just that one was run. "Clinically tested ingredient" can imply the finished product was proven effective. Each phrase needs evidence matched to the meaning shoppers take from it.
The FTC guidance includes examples on these phrases. In one, a "clinically tested ingredient" claim is read as implying the product itself works. In another, a claim of being clinically proven to improve memory was not supported by a study that measured only working memory. The lesson for copywriters is that regulators read the claim the way an ordinary shopper would, not the way the brand's scientist would.
| Phrase | What shoppers likely hear | Evidence you need |
|---|---|---|
| Clinically proven | Science has settled that this product works for this benefit | Strong, consistent RCT evidence on this formula for this benefit |
| Clinically studied | A study showed it works | At least a well-run trial with a meaningful positive result for the stated benefit |
| Clinically tested ingredient | The product works | Evidence that your dose and form deliver the benefit, or wording that clearly limits the claim |
| Backed by research | Research supports the benefit | The totality of good evidence, not a single favorable paper |
| Doctor formulated | Medical expertise shaped and endorses the product | A real, qualified person whose role matches the claim |
If the honest version of the claim sounds weaker, use it. A precise claim that holds up is worth more in ads and listings than a strong one you later have to pull.
How should you present the numbers, charts and study citation?
Show the result that answers the claim, with its context: the comparison group, the measure used, the time point and who took part. Avoid charts that exaggerate small differences. Keep citations that refer to disease uses off the label and packaging, because FDA treats such citations as one way to imply a disease claim.
Numbers and charts
- Compare treatment against placebo, not against the treatment group's own baseline alone.
- If you quote a relative change, give enough context that shoppers understand the actual size of the effect.
- Start chart axes in a way that does not visually inflate differences.
- Name the measure plainly, such as "a standard sleep-quality questionnaire," rather than implying a medical test.
- Report the primary outcome. Do not headline a secondary outcome while burying a neutral primary one.
Citations and third-party literature
Under 21 CFR 101.93(g)(2)(iv)(C), a citation can make a disease claim if it refers to a disease use and the context implies treatment or prevention, for example through placement on the label or packaging or undue prominence. Keep disease-focused citations off packaging.
Section 403B of the FD&C Act, added by DSHEA, lets sellers use certain third-party publications with supplements without them counting as labeling. The conditions are strict. The piece must be reprinted in full, not be false or misleading, not promote a particular brand, be shown with other material to give a balanced view, sit physically apart from the products in a store, and carry nothing appended to it. A brand-funded summary with your logo does not fit that safe harbor.
Do you need to disclose that your brand funded the study?
Yes, when you present the research as independent findings. The FTC's Endorsement Guides give an example: a company funds research run by an outside organization, then cites the results as that group's findings. Because buyers would weigh the results differently if they knew who paid, the funding should be disclosed.
That example sits in 16 CFR 255.5, the section on material connections. It applies even when the outside group designed and ran the study. A short line such as "study funded by [brand]" next to the result is one way to tell people the nature of the connection.
Investigators and experts as spokespeople
Researchers and clinicians are often asked to appear in launch content. Under section 255.3, an endorser presented as an expert must have the expertise claimed, and the endorsement must rest on an actual evaluation of the product at least as thorough as someone with that expertise would normally need. Any payment, consulting fee or equity is a material connection to disclose clearly.
- Match the expert's title and field to the claim they speak to.
- Script them to describe what the study found, not to promise results.
- Keep them away from disease language, even when talking about their clinical work.
- Disclose the relationship in each video and post, not only on a separate page.
The same rules shape creator campaigns that mention the study. Our guide to supplement influencer rules covers creator disclosures.
How do you roll a study out across channels without drifting?
Write one approved study claim, one approved supporting sentence and one disclosure line, then build every asset from those three. Each channel shortens copy differently, so review each format before it runs. Ad platforms also restrict health claims, so check their current policies as well as federal rules.
| Channel | How to use the study | Watch for |
|---|---|---|
| Study landing page | Plain summary, design, population, results, funding, link to the full paper | Disease framing in headings or FAQs |
| Product page and listings | The approved claim plus a link or short summary | "Clinically proven" creeping into titles |
| Paid social and search | The approved claim, unchanged | Shortened versions that overstate; ad platform policies |
| Creators | A brief with the approved claim and disclosure | Personal stories that go beyond the data |
| PR and press | Results with design and funding stated | Headlines written by others that you then quote |
| Retail sell sheets | The approved claim with study details | Buyer-facing shorthand that reaches shoppers |
Structure/function claims drawn from the study still need the FDA disclaimer wherever they appear in labeling. A new structure/function statement on the label also triggers a fresh FDA notification within 30 days of first marketing.
What should sit in the study-claims file, and how does Ichelon Consulting US help?
Keep one file per study claim: the full paper, the protocol, how the tested dose and form compare to your product, the funding and any investigator payments, competing studies, the approved claim wording, and every asset that uses it. Date each approval. If a new study disagrees, re-review the claim.
Re-review triggers
- A reformulation, a new dose or a new delivery form.
- A new study, positive or negative, on the ingredient or benefit.
- A new channel, market or audience segment.
- New FTC or FDA guidance or enforcement on similar claims.
Ichelon Consulting US turns study results into landing pages, ad copy, creator briefs and listing copy that stay inside the approved claim. We are not lawyers or scientists for your study; counsel and your scientific adviser make those calls. Across ICG, we have worked only in healthcare since 2018. US retainers start from $499/month, custom-scoped, with monthly goals and a report every Monday. Explore our supplement and D2C health brand marketing service, or book a call before your study goes public.
Related pages from the US team
Supplement & D2C Health Brand Marketing
How Ichelon Consulting US markets supplement and D2C health brands.
FTC and FDA rules for supplement advertising
Where the disease-claim line sits.
Supplement label and claims review checklist
Sort every claim before launch.
Structure/function claim
What supplements may claim.
Every practice welcome — Goals-Driven engagements from $499/mo
We benchmark your last 90 days, agree monthly goals with you, and track them live on Ichelon Agency OS with a report every Monday. Performance-Linked Payout Models are available. Our US leadership is based in Dallas, and strategy calls run in US business hours.
Common questions
Can a supplement brand say its product is clinically proven?
Only with evidence that matches what the phrase implies. The FTC treats clinically proven as an establishment claim, so it expects strong, consistent randomized controlled human evidence on your formula and dose for the stated benefit. If the evidence covers one ingredient, a different dose or a narrow group, use precise wording that says only what the evidence supports.
Does one positive study substantiate a supplement claim?
Not always. The FTC's Health Products Compliance Guidance says studies cannot be considered in isolation and that advertisers should not rely only on supportive research. A single positive trial may fall short if other good studies disagree, if it used a different dose or form, or if the effect is not clinically meaningful for consumers.
Can a supplement study support a disease claim?
No. A dietary supplement may not claim to diagnose, treat, cure, mitigate or prevent disease, whatever a study shows. Disease claims make the product an unapproved drug. A study can support a structure/function claim, carried with the FDA disclaimer and notified to FDA within 30 days, if it is framed around normal structure or function.
Do I have to disclose that my brand funded a clinical study?
If you present the results as an outside group's findings, yes. The FTC Endorsement Guides give this exact example in 16 CFR 255.5: an advertiser funds research run by an independent organization, and the funding should be disclosed because it could affect how consumers weigh the findings. Payments to investigators who appear in ads must be disclosed too.
Can I put a study citation on a supplement label?
Be careful. Under 21 CFR 101.93(g), a citation to a publication that refers to a disease use can create a disease claim if the context implies treatment or prevention, such as placement on the label or packaging. Keep disease-related citations off packaging, and use citations to structure/function research in labeling only with counsel's review.
What study details should a supplement landing page include?
Include the study design, who took part, the dose and form tested, how long it ran, the primary outcome and result compared with placebo, who funded it, and a link to the full paper. State the approved claim plainly with the FDA disclaimer. Avoid disease language in headings and FAQs, and do not headline secondary outcomes.
A note on this guide: it explains marketing practice, not legal advice. Rules on privacy, advertising and insurance change and vary by state, so confirm anything compliance-related with your own counsel.
Turn your study into claims that hold up
We build study landing pages, ads and creator briefs from one approved claim. Counsel and your scientific adviser confirm the substance.